17-9857500-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004246.3(GLP2R):āc.689T>Cā(p.Val230Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000226 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004246.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLP2R | NM_004246.3 | c.689T>C | p.Val230Ala | missense_variant | 6/13 | ENST00000262441.10 | NP_004237.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLP2R | ENST00000262441.10 | c.689T>C | p.Val230Ala | missense_variant | 6/13 | 1 | NM_004246.3 | ENSP00000262441.5 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251478Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135912
GnomAD4 exome AF: 0.000237 AC: 347AN: 1461848Hom.: 0 Cov.: 31 AF XY: 0.000242 AC XY: 176AN XY: 727228
GnomAD4 genome AF: 0.000118 AC: 18AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2021 | The c.689T>C (p.V230A) alteration is located in exon 6 (coding exon 6) of the GLP2R gene. This alteration results from a T to C substitution at nucleotide position 689, causing the valine (V) at amino acid position 230 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at